文献速递复苏、休克与脓毒症呼吸衰竭与机械通气

球囊面罩通气与气管插管对院外心肺复苏神经功能结局的影响:随机临床试验

Effect of Bag-Mask Ventilation vs Endotracheal Intubation During Cardiopulmonary Resuscitation on Neurological Outcome After Out-of-Hospital Cardiorespiratory Arrest: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01
一句话结论在院外心肺骤停患者中,球囊面罩通气与气管插管相比,未能证明在28天良好神经功能生存率上非劣效或劣效,结果无定论。

该多中心随机临床试验在法国和比利时纳入2043例院外心肺骤停患者,比较初始气道管理采用球囊面罩通气(n=1020)与气管插管(n=1023)对28天良好神经功能结局(脑功能分级1或2)的影响,非劣效界值为1%。结果显示,球囊面罩组28天良好神经功能生存率为4.3%(44/1018),气管插管组为4.2%(43/1022),差异0.11%(单侧97.5%CI -1.64%至无穷),非劣效性检验P=0.11,未能证明非劣效或劣效。两组入院存活率(28.9% vs 32.6%)和28天总生存率(5.4% vs 5.3%)无显著差异。球囊面罩组气道管理困难、失败和胃内容物反流的发生率均显著高于气管插管组。

要点

  • 在院外心肺骤停患者中,球囊面罩通气组28天良好神经功能生存率为4.3%(44/1018),气管插管组为4.2%(43/1022),差异0.11%(单侧97.5%CI -1.64%至无穷),非劣效性检验P=0.11,未能证明非劣效或劣效。
  • 球囊面罩通气组气道管理困难发生率为18.1%(186/1027),气管插管组为13.4%(134/996),差异4.7%(95%CI 1.5%至7.9%),P=0.004。
  • 球囊面罩通气组气道管理失败发生率为6.7%(69/1028),气管插管组为2.1%(21/996),差异4.6%(95%CI 2.8%至6.4%),P<0.001。
  • 球囊面罩通气组胃内容物反流发生率为15.2%(156/1027),气管插管组为7.5%(75/999),差异7.7%(95%CI 4.9%至10.4%),P<0.001。
  • 两组入院存活率(球囊面罩组28.9% vs 气管插管组32.6%,差异-3.7%,95%CI -7.7%至0.3%)和28天总生存率(球囊面罩组5.4% vs 气管插管组5.3%,差异0.1%,95%CI -1.8%至2.1%)无显著差异。

适用人群与场景

  • 院外心肺骤停患者,纳入法国和比利时多中心,年龄均值64.7岁,女性665例(32%)。

诊断标准与关键阈值

  • 主要结局为28天良好神经功能结局,定义为脑功能分级(cerebral performance category)1或2。
  • 非劣效界值为1%。

处置流程与药物剂量

  • 参与者随机接受初始气道管理为球囊面罩通气(n=1020)或气管插管(n=1023)。

研究设计与关键结果

  • 多中心随机临床试验,纳入2043例院外心肺骤停患者,随机分为球囊面罩通气组(n=1020)和气管插管组(n=1023),2040例(99.8%)完成试验。
  • 在意向治疗人群中,28天良好神经功能生存率球囊面罩组为4.3%(44/1018),气管插管组为4.2%(43/1022),差异0.11%(单侧97.5%CI -1.64%至无穷),非劣效性检验P=0.11,未能证明非劣效或劣效。
  • 入院存活率球囊面罩组为28.9%(294/1018),气管插管组为32.6%(333/1022),差异-3.7%(95%CI -7.7%至0.3%),无显著差异。
  • 28天总生存率球囊面罩组为5.4%(55/1018),气管插管组为5.3%(54/1022),差异0.1%(95%CI -1.8%至2.1%),无显著差异。
  • 气道管理困难发生率球囊面罩组为18.1%(186/1027),气管插管组为13.4%(134/996),差异4.7%(95%CI 1.5%至7.9%),P=0.004。
  • 气道管理失败发生率球囊面罩组为6.7%(69/1028),气管插管组为2.1%(21/996),差异4.6%(95%CI 2.8%至6.4%),P<0.001。
  • 胃内容物反流发生率球囊面罩组为15.2%(156/1027),气管插管组为7.5%(75/999),差异7.7%(95%CI 4.9%至10.4%),P<0.001。

证据类型、等级与局限

  • 证据类型:多中心随机临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在院外心肺骤停的初始气道管理中,球囊面罩通气与气管插管相比,28天良好神经功能生存率未能证明非劣效或劣效,结果无定论;作者认为确定两种技术间的等效性或优效性需要进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Bag-mask ventilation (BMV) is a less complex technique than endotracheal intubation (ETI) for airway management during the advanced cardiac life support phase of cardiopulmonary resuscitation of patients with out-of-hospital cardiorespiratory arrest. It has been reported as superior in terms of survival.

OBJECTIVES: To assess noninferiority of BMV vs ETI for advanced airway management with regard to survival with favorable neurological function at day 28.

DESIGN, SETTINGS, AND PARTICIPANTS: Multicenter randomized clinical trial comparing BMV with ETI in 2043 patients with out-of-hospital cardiorespiratory arrest in France and Belgium. Enrollment occurred from March 9, 2015, to January 2, 2017, and follow-up ended January 26, 2017.

INTERVENTION: Participants were randomized to initial airway management with BMV (n = 1020) or ETI (n = 1023).

MAIN OUTCOMES AND MEASURES: The primary outcome was favorable neurological outcome at 28 days defined as cerebral performance category 1 or 2. A noninferiority margin of 1% was chosen. Secondary end points included rate of survival to hospital admission, rate of survival at day 28, rate of return of spontaneous circulation, and ETI and BMV difficulty or failure.

RESULTS: Among 2043 patients who were randomized (mean age, 64.7 years; 665 women [32%]), 2040 (99.8%) completed the trial. In the intention-to-treat population, favorable functional survival at day 28 was 44 of 1018 patients (4.3%) in the BMV group and 43 of 1022 patients (4.2%) in the ETI group (difference, 0.11% [1-sided 97.5% CI, -1.64% to infinity]; P for noninferiority = .11). Survival to hospital admission (294/1018 [28.9%] in the BMV group vs 333/1022 [32.6%] in the ETI group; difference, -3.7% [95% CI, -7.7% to 0.3%]) and global survival at day 28 (55/1018 [5.4%] in the BMV group vs 54/1022 [5.3%] in the ETI group; difference, 0.1% [95% CI, -1.8% to 2.1%]) were not significantly different. Complications included difficult airway management (186/1027 [18.1%] in the BMV group vs 134/996 [13.4%] in the ETI group; difference, 4.7% [95% CI, 1.5% to 7.9%]; P = .004), failure (69/1028 [6.7%] in the BMV group vs 21/996 [2.1%] in the ETI group; difference, 4.6% [95% CI, 2.8% to 6.4%]; P < .001), and regurgitation of gastric content (156/1027 [15.2%] in the BMV group vs 75/999 [7.5%] in the ETI group; difference, 7.7% [95% CI, 4.9% to 10.4%]; P < .001).

CONCLUSIONS AND RELEVANCE: Among patients with out-of-hospital cardiorespiratory arrest, the use of BMV compared with ETI failed to demonstrate noninferiority or inferiority for survival with favorable 28-day neurological function, an inconclusive result. A determination of equivalence or superiority between these techniques requires further research.

TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02327026.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Jabre P, Penaloza A, Pinero D, et al. Effect of Bag-Mask Ventilation vs Endotracheal Intubation During Cardiopulmonary Resuscitation on Neurological Outcome After Out-of-Hospital Cardiorespiratory Arrest: A Randomized Clinical Trial. JAMA. 2018. PMID: 29486039. doi:10.1001/jama.2018.0156

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。